Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 52Carcinoma, Renal Cell 47Neoplasm Metastasis 24Neoplasms 18Kidney Neoplasms 18Neuroendocrine Tumors 17Carcinoma, Non-Small-Cell Lung 13Tuberous Sclerosis 12Stomach Neoplasms 12Lymphoma, Mantle-Cell 12Lymphoma, Large B-Cell, Diffuse 11Recurrence 10Prostatic Neoplasms 10Lymphoma 10Hodgkin Disease 10Glioblastoma 10Colorectal Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Brain Neoplasms 9Lymphoma, Follicular 8Lung Neoplasms 8Leukemia, Lymphocytic, Chronic, B-Cell 8Carcinoma 8Waldenstrom Macroglobulinemia 7Triple Negative Breast Neoplasms 7Sarcoma 7Multiple Myeloma 7Lymphoma, B-Cell, Marginal Zone 7Glioma 7Central Nervous System Neoplasms 7

Interventions

Everolimus 3Bevacizumab 3Lapatinib 2vistusertib 1icotinib 1Vascular Endothelial Growth Factor A 1Sunitinib 1Sirolimus 1Magnetic Resonance Imaging 1Exome 1Endostatins 1Crizotinib 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neurofibromatosis 2 × Everolimus × Clear all
NCT01880749 2020-05-13

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

NYU Langone Health

Phase EARLY_PHASE1 Completed
5 enrolled
CNS

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT01419639 2017-07-18

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

NYU Langone Health

Phase 2 Completed
10 enrolled 4 charts
CNS

Ependymoma, Meningioma, Neurofibromatosis 2

NCT01490476 2017-05-23

AFINF2

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
10 enrolled
CNS

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡